Unlock instant, AI-driven research and patent intelligence for your innovation.

Transdermal drug delivery formulation

A kind of technology of transdermal agent and anti-inflammatory drug, applied in the field of transdermal release dosage form

Inactive Publication Date: 2008-10-29
NUVO RES
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the transdermal dosage form taught by Sandborn has its advantages in this field, there is still room for improvement

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transdermal drug delivery formulation
  • Transdermal drug delivery formulation
  • Transdermal drug delivery formulation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
surface areaaaaaaaaaaa
Login to View More

Abstract

The present invention provides a transdermal formulation for the delivery of at least one active agent. The formulation includes (i) a first compound comprising an organic sulfoxide, and (ii) a second compound selected from the group consisting of a fatty acid ester, a fatty acid, an azone-related compound and mixtures thereof.

Description

transdermal drug form technical field The invention relates to a transdermal release dosage form. In a particularly preferred embodiment, the present invention relates to a transdermal dosage form comprising dimethyl sulfoxide (DMSO) and a compound selected from the group consisting of fatty acid esters, fatty acids, azone compounds and A group consisting of mixtures thereof. Background technique Transdermal drug delivery involves the administration of an active agent for local or systemic distribution through the skin to disease-affected tissues. Transdermal administration of active agents avoids first-pass metabolic effects and alleviates some of the problems associated with oral administration of active agents to the gastrointestinal (GI) system. For example, oral administration of NSAIDs can cause significant adverse gastrointestinal (GI) side effects. Topical regimens can reduce the incidence of gastrointestinal adverse events by avoiding or reducing the release of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/70A61K31/196A61K47/14A61K47/20
CPCA61K9/0014A61K31/196A61K47/12A61K47/14A61K47/16A61K47/20A61P29/00
Inventor 杰加特·辛格
Owner NUVO RES